Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Neuroinflammation during stroke and Gaucher’s disease : How monocyte-derived macrophages and microglia shape the inflammatory environment of the brain

Författare

  • Juliane Tampe

Summary, in English

The human brain is a complex and finely tuned organ, constantly monitored and maintained by its resident immune cells.
Among these, microglia are the primary regulators of the brain immune environment under physiological conditions, and monocyte-derived macrophages contribute mainly to pathological states such as ischemic stroke and neuronopathic Gaucher’s disease (GD). These two diseases, although different in origin, one acute and vascular, the other chronic and genetic, share a common feature: a disruption in immune homeostasis marked by neuroinflammation.
Using flow cytometry, gene expression profiling, and induced pluripotent stem cell (iPSC)-derived cell modeling, this work demonstrated that monocytes and microglia are dynamically regulated by intrinsic factors and extrinsic stimuli. During human aging, circulating monocyte subsets undergo sex-dependent transcriptional remodeling, with females exhibiting stronger anti-inflammatory aging signatures. This was particularly evident in the upregulation of ANXA1 in female non-classical monocytes. Additionally, age-associated increases in the scavenger receptor CD36 were observed across all monocyte subtypes.
In ischemic stroke patients, monocyte frequency and gene expression patterns predict recovery, particularly through the expansion of intermediate monocytes and the downregulation of inflammatory mediators. A panel of recovery-associated markers: CD91, CD36, TGM2, SLC24A4, and CD38, were identified, with CD36 in intermediate monocytes emerging as a novel marker of recovery.
In neuronopathic GD, human iPSC-derived microglia (hiMG) exhibit intrinsic impairments in cytokine signaling and lysosomal function under immune stimulation, indicating chronic neuroimmune dysfunction. These changes suggest a brain-specific immune phenotype distinct from peripheral macrophages and support a role for microglia in GD-associated neurodegeneration.
In summary, this thesis explores how peripheral monocytes and brain-resident microglia, both part of the mononuclear phagocyte system, shape the neuroinflammatory processes during aging, ischemic stroke, and GD. It highlights how immune responses are influenced by age, sex, and disease state, providing mechanistic insight and models for developing future immune-targeted therapies for neurological diseases.

Publiceringsår

2025

Språk

Engelska

Publikation/Tidskrift/Serie

Lund University, Faculty of Medicine Doctoral Dissertation Series

Avvikelse

2025:91

Dokumenttyp

Doktorsavhandling

Förlag

Lund University, Faculty of Medicine

Ämne

  • Neurosciences

Nyckelord

  • Monocytes
  • Stroke
  • Gene expression
  • Neuroinflammation
  • Recovery
  • iPSC-derived microglia
  • Gaucher's disease
  • Lysosomal dysfunction
  • Disease modeling

Aktiv

Published

Projekt

  • Characterisation of human monocytes for age and gender signatures and during stroke

Forskningsgrupp

  • Stem Cells & Restorative Neurology

Handledare

  • Zaal Kokaia
  • Emanuela Monni
  • Arne Lindgren
  • Henrik Ahlenius
  • Olle Lindvall

ISBN/ISSN/Övrigt

  • ISSN: 1652-8220
  • ISBN: 978-91-8021-744-6

Försvarsdatum

18 september 2025

Försvarstid

09:00

Försvarsplats

Segerfalksalen, BMC A10, Sölvegatan 17 i Lund

Opponent

  • Kate Lykke Lambertsen (Associate Professor)